Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Wing-Lok Chan
Cheuk-Wai Choi
Ian Yu-Hong Wong
Terence Hon-Ting Tsang
Adrian Tin-Chung Lam
Rosa Pui-Ying Tse
K. K. Chan
Claudia Wong
Betty Tze-Ting Law
Emina Edith Cheung
Siu-Yin Chan
Ka-On Lam
Dora Kwong
Simon Law
机构：
[1] The University of Hong Kong,Department of Clinical Oncology, LKS Faculty of Medicine
[2] The University of Hong Kong,School of Public Health, LKS Faculty of Medicine
[3] The University of Hong Kong,Department of Surgery, LKS Faculty of Medicine
[4] The University of Hong Kong,LKS Faculty of Medicine
[5] Queen Mary Hospital,Department of Clinical Oncology
[6] Queen Mary Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 870
页数：9
相关论文
共 50 条
  • [1] ASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    Choi, Cheuk-Wai
    Wong, Ian Yu-Hong
    Tsang, Terence Hon-Ting
    Lam, Adrian Tin-Chung
    Tse, Rosa Pui-Ying
    Chan, K. K.
    Wong, Claudia
    Law, Betty T. T.
    Cheung, Emina Edith
    Chan, Siu-Yin
    Lam, Ka-On
    Kwong, Dora
    Law, Simon
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 873 - 873
  • [2] ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 871 - 872
  • [3] ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Annals of Surgical Oncology, 2023, 30 : 871 - 872
  • [4] The Efficacy and safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin, 5-FU therapy for resectable locally advanced esophageal squamous cell carcinoma
    Ogura, N.
    Yamamoto, S.
    Hirose, T.
    Shiraishi, K.
    Imazeki, H.
    Itoyama, M.
    Yokoyama, K.
    Honma, Y.
    Kurita, D.
    Ishiyama, K.
    Oguma, J.
    Daiko, H.
    Seto, Y.
    Kato, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1479 - S1479
  • [5] Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma.
    Hirose, Toshiharu
    Yamamoto, Shun
    Kadono, Toru
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 312 - 312
  • [6] Cetuximab plus chemoradiation with cisplatin and 5-fluorouracil (5-FU) in locally advanced unresectable esophageal squamous cell carcinoma.
    Sunpaweravong, P.
    Sunpaweravong, S.
    Sangthawan, D.
    Pinaikul, S.
    Attasaranya, S.
    Dechaphunkul, A.
    Mitarnun, W.
    Fungthammasarn, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Neoadjuvant triplet chemotherapy with docetaxel, cisplatin plus 5-FU vs docetaxel, cisplatin plus S-1 for advanced esophageal squamous cell carcinoma: Propensity score matched analysis
    Kitadani, Junya
    Ojima, Toshiyasu
    Hayata, Keiji
    Goda, Taro
    Takeuchi, Akihiro
    Tominaga, Shinta
    Fukuda, Naoki
    Nakai, Tomoki
    Yamaue, Hiroki
    Kawai, Manabu
    ONCOLOGY, 2024, 102 (03) : 228 - 238
  • [8] A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma
    Ling, Yang
    Chen, Jia
    Tao, Min
    Chu, Xiaoyuan
    Zhang, Xizhi
    JOURNAL OF THORACIC DISEASE, 2012, 4 (01) : 58 - 62
  • [9] Concomitant chemoradiotherapy using docetaxel, cisplatin, and 5-FU for the patients with advanced squamous cell carcinoma of the temporal bone
    Shiga, Kiyoto
    Katagiri, Katsunori
    Ogawa, Takenori
    Kato, Kengo
    Asada, Yukinori
    Kobayashi, Toshimitsu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] CISPLATIN AND 5-FU INFUSIONS IN THERAPY OF ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK IN 50 INDIAN PATIENTS
    SHARMA, SC
    SHARMA, AK
    SINGHAL, KC
    ACTA PHARMACOLOGICA SINICA, 1990, 11 (03): : 288 - 288
12345